Gene · 1237
NIH grants1,226
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 1,226
Download this page as JSON| Grant | Title | CCR8 papers | Newest fiscal year |
|---|---|---|---|
| R01HL141917 | Improving Mitral Compensation In Ischemic Regurgitation | 1 | 2021 |
| R01NS094573 | Regulatory T cell as a restorative therapy for ischemic stroke | 1 | 2021 |
| R01NS099596 | Creating Endogenous Stem Cell Niches to Promote Functional Brain Repair Post-TBI | 1 | 2021 |
| R01NS101718 | Whole Genome RNA Sequencing (RNAseq) of Blood from Patients with Lacunar Stroke | 1 | 2021 |
| R01NS104016 | Eradication of latent SIV from the CNS | 1 | 2021 |
| R03HL154275 | Regulation of Neutrophilic Airway Inflammation by miR-223-3p | 1 | 2021 |
| R21AI144677 | Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta | 1 | 2021 |
| R21AI150657 | Investigating mechanisms of epidermal cell death in Toxic Epidermal Necrolysis | 1 | 2021 |
| R25GM059994 | The Meharry RISE initiative | 1 | 2021 |
| R25GM069621 | RISE Research Scholars Program | 1 | 2021 |
| R33CA225498 | Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers | 1 | 2021 |
| R43AG074715 | Optimization of a Chemokine Receptor Antagonist Peptide as a Synapse Protecting Treatment for Neurodegeneration in Alzheimer's Disease | 1 | 2021 |
| R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 1 | 2021 |
| R44NS120541 | Development of a Novel Chemokine Receptor Antagonist Peptide as a Non-Opioid Treatment for Relief of Chronic Pain | 1 | 2021 |
| T32CA203702 | Molecular and Translational Oncology Research | 1 | 2021 |
| T32GM007171 | Medical Scientist Training Program | 1 | 2021 |
| T32GM007753 | Medical Scientist Training Program | 1 | 2021 |
| T32GM008152 | Medical Scientist Training Program | 1 | 2021 |
| T32HL066988 | MULTIDISCIPLINARY TRAINING IN PULMONARY RESEARCH | 1 | 2021 |
| U01AI101984 | Tissue Cytokine Sequestration and Immune Regulation in Autoimmunity | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/grants?page=19